Skip to main content

Advertisement

Contact Serge Leyvraz

From: MART-1 peptide vaccination plus IMP321 (LAG-3Ig fusion protein) in patients receiving autologous PBMCs after lymphodepletion: results of a Phase I trial

Contact corresponding author